23.68USD-6.18%Mkt Cap: 42.32M $P/E: —1d ago
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a…
Industry Peers
Diagnostics & Research$201.86BUSDP/E 29.8
$145.10BUSDP/E 39.7
$45.85BUSDP/E 44.2
$45.44BUSDP/E 42.4
$38.64BUSD
$38.44BUSDP/E 27.3
$37.13BUSDP/E 48.1
$35.13BUSDP/E 26.2
$28.78BUSDP/E 34.6
$26.98BUSDP/E 31.4
$23.18BUSDP/E 23.1
$23.12BUSDP/E 25.0
$20.55BUSD
$15.36BUSDP/E 33.9
$13.06BUSDP/E 27.3
$12.46BUSDP/E 53.7
$11.04BUSD
$9.26BUSDP/E 21.6
$5.90BUSDP/E 237.4
$5.68BUSD
$5.21BUSDP/E 44.6
$4.95BUSD
$4.73BUSDP/E 54.8
$3.75BUSDP/E 26.5
$3.54BUSD
$3.09BUSD
$2.08BUSD
$1.93BUSD
$1.83BUSD
$1.64BUSDP/E 41.7
$1.63BUSD
$1.48BUSDP/E 22.4
$1.02BUSDP/E 21.4
$898.56MUSD
$734.89MUSD
$616.40MUSDP/E 40.2
$584.63MUSD
$583.63MUSD
$293.12MUSDP/E 2.9
$292.75MUSD
$206.70MUSD
$152.09MUSD
$139.43MUSD
$97.25MUSD
$102.68MUSD
$89.37MUSDP/E 17.2
$73.19MUSD
$58.55MUSD
$30.71MUSD
$26.61MUSD
$20.94MUSD
$16.60MUSD
$12.04MUSD
$9.95MUSD
$8.70MUSD
$8.87MUSD
$7.73MUSD
$7.43MUSD
$6.69MUSD
$6.06MUSD
$5.06MUSD
$4.47MUSD
$4.44MUSD
$2.95MUSD
$3.29MUSD
$3.18MUSD
$869.0KUSD
$314.2KUSDP/E Infinity
$19.6KUSD
Indicators:|
Key Statistics
Company
Market Cap42.32M $
Enterprise Value43.21M $
Revenue (TTM)25.83M $
Gross Profit10.71M $
Net Income (TTM)-363.00K $
Revenue/Share15.42 USD
Last Price23.68 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees61
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS74019L5030
Valuation
P/E (Trailing)—
P/E (Forward)60.72
PEG—
EV/EBITDA-121.39
EV/Revenue1.67
P/S1.64
P/B2.98
EPS (TTM)-0.45
EPS (Forward)0.39
52W Range
13.0252% of range33.63
52W High33.63 USD
52W Low13.02 USD
Profitability
Gross Margin44.52%
Oper. Margin-21.28%
EBITDA Margin-1.38%
Profit Margin-1.51%
ROE-2.49%
ROA-1.70%
Growth
Revenue Growth36.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF685.00K $
CapEx (TTM)326.00K $
FCF Margin2.49%
FCF Yield1.52%
Net Debt888.00K $
Net Debt/EBITDA-2.49
Balance Sheet
Debt/Equity0.25
Current Ratio1.56
Quick Ratio1.21
Book Value/Sh7.943 USD
Cash/Share1.457 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 29, 2019
Splits
Last Split1:20
Split DateSep 22, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.79M
Float1.41M
Insiders12.59%
Institutions17.66%
Short Interest
Short Ratio0.9d
Short % Float1.69%
Short % Out.1.53%
Shares Short27.43K
Short (prev mo.)12.43K
Technical
SMA 5024.83 (-4.6%)
SMA 20024.12 (-1.8%)
Beta1.28
S&P 52W Chg20.25%
Avg Vol (30d)53.48K
Avg Vol (10d)84.96K
Technical Indicators
RSI (14)47.1
MACD0.0520
MACD Signal0.0059
MACD Hist.+0.0461
BB Upper26.49 USD
BB Middle23.95 USD
BB Lower21.42 USD
BB Width21.18%
ATR (14)1.909 USD
Vol Ratio (20d)3.36x